PTYLTD
    • Free Reports
    • Videos
  • Pricing
  • About us
  • Contact us
  • Login | Sign up
PTYLTD

Free Reports

Videos

Pricing

About us

Contact us

Blogs

ANZ Group Holdings (ASX: ANZ)

ANZ Group Holdings (ASX: ANZ): Repricing Discipline and Transformation Momentum

Jul 9, 2026
Proactive Equities Team

ANZ Group Holdings (ASX: ANZ) delivers resilient profitability, disciplined cost control, and strong capital ratios, positioning for sustained shareholder returns amid strategic transformation and integration momentum

Minerals 260 (ASX: MI6)

Minerals 260 (ASX: MI6) Breaches Key Support: Is the Bull Run Over?

Jul 9, 2026
Proactive Equities Team

Minerals 260 has boosted Bullabulling to a 6.2Moz gold resource and unveiled a maiden reserve and PFS supporting a 19-year mine. Despite strong fundamentals, MI6 has slipped below trendline support, prompting investors to watch key technical levels closely

Sigma Healthcare (ASX: SIG)

Sigma Healthcare (ASX: SIG): Integrated Scale, Relentless Momentum

Jul 8, 2026
Proactive Equities Team

Sigma Healthcare (ASX: SIG) delivers strong double‑digit growth and disciplined integration, positioning the merged Chemist Warehouse group for sustained expansion across domestic and international markets

Island Pharmaceuticals (ASX: ILA)

Island Pharmaceuticals (ASX: ILA) Breaks Its Downtrend as Galidesivir News Puts It Back in Play

Jul 8, 2026
Proactive Equities Team

Island Pharmaceuticals has regained market attention after breaking a long-term downtrend, supported by Galidesivir developments and strong trading momentum. Recent updates across biodefence, manufacturing, and intellectual property have improved sentiment, although confirmation above key resistance remains important

DevEx Resources (ASX: DEV)

DevEx Resources (ASX: DEV) Draws Renewed Attention as Key Catalysts Build

Jul 7, 2026
Proactive Equities Team

DevEx Resources (ASX: DEV) is an Australian uranium explorer advancing its flagship Nabarlek project. While buoyed by strong uranium markets and strategic acquisitions, the consolidating stock faces high exploration risks, significant cash burn, and reliance on upcoming drilling success

Core Lithium (ASX: CXO)

Core Lithium (ASX: CXO): Finniss Restart and Tactical Re‑rating

Jul 7, 2026
Proactive Equities Team

Core Lithium (ASX: CXO) advances its Finniss restart with full funding, disciplined execution, and improving lithium sentiment, positioning for a tactical rebound as operations resume and technical momentum builds.

Cobre (ASX: CBE)

Cobre (ASX: CBE)’s Copper Pivot: Cash flow, Chile Expansion & Chart nerves

Jul 6, 2026
Proactive Equities Team

Cobre is shifting from exploration to production, backed by positive cash flow at Sierra Atacama and ongoing Botswana exploration. While the share price remains strong, investors are watching whether the company can sustain operational momentum and long-term growth.

Computershare (ASX: CPU)

Computershare (ASX: CPU): Consistent Growth and Margin Resilience

Jul 6, 2026
Proactive Equities Team

Computershare (ASX: CPU) delivers consistent earnings growth and margin resilience through disciplined cost control, strong cash generation, and capital‑light operations, positioning for sustained shareholder returns.

Suncorp Group (ASX: SUN)

Suncorp Group (ASX: SUN): Re‑Establishing Margin Strength Through Digital Scale and Capital Discipline

Jul 6, 2026
Proactive Equities Team

Suncorp Group (ASX: SUN) delivers resilient margins despite elevated natural hazards, supported by AI‑driven transformation, disciplined capital management, and strong portfolio optimisation.

Solstice Minerals (ASX: SLS)

Solstice Minerals (ASX: SLS) Breaks Out as Nanadie Turns into a Bigger Copper- Gold Story

Jul 5, 2026
Proactive Equities Team

Solstice Minerals has gained momentum after strong drilling results at its Nanadie copper-gold project. The explorer is expanding its resource potential, backed by fresh funding, multiple exploration targets, and a bullish share price breakout supported by rising trading volume.

Weebit Nano(ASX: WBT)

Weebit Nano (ASX: WBT) Breaks Gear as ReRAM Moves from Promise to Production

Jul 4, 2026
Proactive Equities Team

Weebit Nano is gaining investor attention as commercial progress accelerates. Licensing deals, JEDEC qualification, product tape-outs, stronger revenue, and fresh funding have boosted confidence. At the same time, the share price remains technically strong with buyers defending key support levels after a significant breakout.

Fundamental Analysis

Fundamental Analysis: What It Is, Its Main Types, and How to Use It

Jul 3, 2026
Proactive Equities Team

Fundamental analysis calculates a security's intrinsic value by evaluating macroeconomic, industry, and company-specific financial data. Unlike technical analysis, this long-term strategy identifies mispriced assets based on underlying business health, though it demands significant research, reliable data, and patience

Challenger (ASX: CGF)

Challenger (ASX: CGF): The Business Case Behind the Recent Shift in Sentiment

Jul 2, 2026
Proactive Equities Team

Challenger (ASX: CGF) delivers disciplined growth and capital strength, positioning itself as Australia’s leading retirement‑income compounder with expanding annuity sales, resilient margins and a robust balance sheet.

Manuka Resources (ASX: MKR)

Manuka Resources (ASX: MKR) Pulls Back as the Restart Rally Meets Its First Real Test

Jul 2, 2026
Proactive Equities Team

Manuka Resources is retracing after its May rally as investors await production milestones. With gold processing expected in July and silver production targeted for September, the market is looking for operational results to confirm the company's restart strategy.

Inoviq (ASX: IIQ)

Inoviq (ASX: IIQ)'s Breakout Reverses Hard: IIQ Slides After EXO-OC Study Reset

Jul 2, 2026
Proactive Equities Team

Inoviq shares plunged after sample-quality issues delayed validation of its EXO-OC ovarian cancer test, despite improved algorithm performance. The sharp reversal has shifted investor focus from growth potential to execution risks, timelines, and confidence in the company’s development strategy.

Macquarie Group (ASX: MQG)

Macquarie Group (ASX: MQG): A High‑Conviction Financial Powerhouse

Jul 1, 2026
Proactive Equities Team

Macquarie Group (ASX: MQG) delivers muscular earnings growth, disciplined capital management and diversified global momentum, positioning itself as Australia’s premier financial powerhouse with sustainable mid‑teen returns and expanding shareholder value.

QBE Insurance Group (ASX: QBE)

QBE Insurance Group (ASX: QBE): High-Conviction Income and Compounding Returns

Jul 1, 2026
Proactive Equities Team

QBE Insurance Group (ASX: QBE) delivers disciplined underwriting, robust investment returns and rising capital returns, offering high-conviction, income-led exposure to global commercial insurance with upside from sustained double-digit ROE and capital-efficient growth.

Trending Markets

What Is a Trending Market? A Complete Guide to Identifying Trending Markets and Growing Profits

Jun 30, 2026
Proactive Equities Team

Successful trading depends on aligning with market conditions, especially trends. This article explains how to distinguish trending from range-bound markets, identify uptrends and downtrends, use key technical tools for entries and exits, and avoid common mistakes that lead to losses.

Judo Capital Holdings (ASX: JDO)

Judo Capital Holding (ASX: JDO) Credit Shock: Falls Hard, but the Chart Is Now Screaming “Decision Point”

Jun 30, 2026
Proactive Equities Team

Judo Capital (ASX: JDO) has dropped sharply after a credit-quality shock, lifting cost-of-risk guidance and cutting profit forecasts. Heavy selling, oversold technicals, and weak sentiment now define the stock, though long-term growth signals remain partly intact.

Ansell (ASX: ANN)

Ansell (ASX: ANN): Margin Expansion and Operational Resilience Through Transition

Jun 28, 2026
Proactive Equities Team

Ansell (ASX: ANN) delivers double‑digit earnings growth, disciplined cost control, and strong cash conversion amid subdued market conditions, reinforcing margin resilience and balance‑sheet strength.

Mesoblast (ASX: MSB)

Mesoblast (ASX: MSB) Shares Declined Despite Ryoncil Momentum as Investors Lock In Profits

Jun 28, 2026
Proactive Equities Team

Mesoblast (ASX: MSB) is transitioning into a commercial-stage biotech as Ryoncil® sales accelerate and its late-stage pipeline advances. While the share price has eased after a strong rally, growing revenue, improving cash flow, and multiple clinical catalysts continue to support its long-term outlook.

Proactive Equities

At Proactive Equities, we combine deep market expertise with rigorous analysis to deliver stock recommendations you can trust. Our team of seasoned analysts continuously monitor global markets, economic trends, and company fundamentals to identify high-potential investment and trade opportunities.

Company

Home
Pricing
Contact Us
About Us

Resources

ASX Insights
Investing Basics

Links

Privacy Policy
Terms and Conditions
Product Disclosure Statement

Proactive Equities Pty Ltd (ACN: 687 232 471) is a Corporate Authorised Representative (AFSR No. 001318293) of Australia National Investment Group Pty Ltd (ABN: 40 636 343 630), which holds an Australian Financial Services Licence (AFSL no. 522028). The information on this website is general information only and does not constitute personal financial advice. We have not taken the individual circumstances, financial objectives or needs of any investor into account when preparing this information. Investors should consider their circumstances and the relevant PDS for any investment and obtain professional financial and tax advice before making any investment decision. The information on this website is not a recommendation to make any investment or to adopt any particular investment strategy. You should make your own professional assessment of the suitability of this information, relying on your own inquiries. Investments in securities are subject to investment risk. Investment value may go down as wellas up, and investors may not get back the full amount originally invested. Risks include: the investment objective may not be achieved, share market and other market risk, liquidity risk, and currency risk with international investments. Any past performance shown is not an indication of future performance. Commission and other costs charged by executing broker are not considered when calculating past performance. To the extent permitted by law Proactive Equities Pty Ltd accepts no liability for any errors or omissions in, or loss from reliance on the information in this website.

Editor's Picks
12345...12
Page 2 of 12